Skip to main content
Tags: pfizer | trump | vaccine | covidaVW

Pfizer Tried to Downplay Trump Help, $1.95 Billion Pledge to Buy Vaccine

the pfizer logo on a marble wall
The Pfizer world headquarters stands in New York City.   (Drew Angerer/Getty Images)

By    |   Tuesday, 10 November 2020 06:24 PM EST

Pfizer, one of the drug makers racing to develop a coronavirus vaccine, on Tuesday backtracked after distancing itself from Trump’s Operation Warp Speed.

Pfizer on Monday said an early analysis of its trial suggested the vaccine was robustly effective in preventing the coronavirus – an announcement quickly followed by tweets from several Trump administration officials taking credit for its development.

"HUGE NEWS: Thanks to the public-private partnership forged by President @realDonaldTrump, @pfizer announced its Coronavirus Vaccine trial is EFFECTIVE, preventing infection in 90% of its volunteers," Vice President Mike Pence tweeted Monday.

“Thanks to the tireless work of Operation Warp Speed and the partnership it struck with Pfizer, HHS & the Military in July to support distribution + logistics, Pfizer can massively scale production and nationwide delivery of +100 M doses of the vaccine!” Ivanka Trump tweeted.

Pfizer did not accept federal money for research into a coronavirus vaccine and Kathrin Jansen, the company’s vice president for vaccine research, told the New York Times it was never “part of the Warp Speed. We have never taken any money from the U.S. government, or from anyone.”

But the company in July agreed to sell at least 100 million doses of its vaccine to the federal government for $1.95 billion.

Pfizer spokesperson Sharon Castillo on Tuesday told CNN  that the company is indeed part of Operation Warp Speed.

"Pfizer is one of various vaccine manufacturers participating in Operation Warp Speed as a supplier of a potential COVID-19 vaccine," Castillo said in an email. "While Pfizer did reach an advanced purchase agreement with the U.S. government, the company did not accept (Biomedical Advanced Research and Development Authority) funding for the research and development process. All the investment for R&D was made by Pfizer at risk. Dr. Jansen was emphasizing that last point."

Solange Reyner

Solange Reyner is a writer and editor for Newsmax. She has more than 15 years in the journalism industry reporting and covering news, sports and politics.

© 2025 Newsmax. All rights reserved.


Newsfront
Pfizer, one of the drug makers racing to develop a coronavirus vaccine, on Tuesday backtracked after distancing itself from Trump's Operation Warp Speed....
pfizer, trump, vaccine, covidaVW
300
2020-24-10
Tuesday, 10 November 2020 06:24 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved